Sun Life Reports Fourth Quarter and Full Year 2022 Results
Sun Life Financial Inc. (SLF) reported its Q4 2022 results, showing a 12% decrease in reported net income to $951 million compared to Q4 2021. However, underlying net income increased 10% to $990 million. For the full year, reported net income fell 22% to $3,060 million, while underlying net income rose 4% to $3,674 million. The company saw strong insurance sales growth of 18% in 2022 and $21.5 billion in inflows at SLC Management. Key financial ratios included a reported ROE of 12.5% for 2022. Sun Life will adopt IFRS 17 and IFRS 9 starting January 1, 2023, expected to positively influence its LICAT ratio and underlying EPS growth.
- Underlying net income increased 10% to $990 million in Q4 2022.
- 18% increase in insurance sales in 2022, demonstrating strong market demand.
- $21.5 billion of inflows at SLC Management highlights strong capital management.
- Canada reported a 22% increase in underlying net income, driven by favorable morbidity.
- U.S. reported 29% increase in net income driven by strong performance and DentaQuest acquisition.
- Reported net income decreased 12% to $951 million in Q4 2022, primarily due to unfavorable market impacts.
- Full year reported net income fell 22% compared to the previous year.
- Asset Management segment saw a decline in AUM and net outflows totaling $12.6 billion in Q4 2022.
The information in this document is based on the unaudited interim financial results of |
- Q4'22 reported net income of
decreased$951 million 12% from Q4'21; reported ROE(1) was15.1% . - Q4'22 underlying net income(1) of
increased$990 million 10% from Q4'21; underlying ROE(1) was15.7% . - 2022 reported net income of
decreased$3,060 million 22% from 2021; reported ROE(1) was12.5% . - 2022 underlying net income(1) of
increased$3,674 million 4% from 2021; underlying ROE(1) was15.1% .
"Sun Life delivered strong fourth quarter results led by earnings growth in the
"In 2022, we continued to drive our Client Impact Strategy, helping our approximately 85 million global Clients achieve lifetime financial security and live healthier lives. We built new digital tools and processes and added solutions to elevate Client experience and their evolving needs. We also expanded our scale and capabilities by effectively deploying capital through new bancassurance agreements in
Quarterly results | Year-to-date | ||||
Profitability | Q4'22 | Q4'21 | 2022 | 2021 | |
Reported net income - Common shareholders ($ millions) | 951 | 1,078 | 3,060 | 3,934 | |
Underlying net income ($ millions)(1) | 990 | 898 | 3,674 | 3,533 | |
Reported EPS ($)(2) | 1.62 | 1.83 | 5.21 | 6.69 | |
Underlying EPS ($)(1)(2) | 1.69 | 1.53 | 6.27 | 6.03 | |
Reported return on equity ("ROE")(1) | 15.1 % | 18.0 % | 12.5 % | 17.1 % | |
Underlying ROE(1) | 15.7 % | 15.0 % | 15.1 % | 15.4 % | |
Growth | Q4'22 | Q4'21 | 2022 | 2021 | |
Insurance sales ($ millions)(1) | 1,843 | 1,606 | 4,321 | 3,674 | |
Wealth sales and asset management gross flows ($ millions)(1) | 45,754 | 56,708 | 204,113 | 228,408 | |
Value of new business ("VNB") ($ millions)(1) | 468 | 494 | 1,253 | 1,346 | |
Assets under management ("AUM") ($ billions)(1)(3) | 1,326 | 1,445 | |||
Financial Strength | Q4'22 | Q4'21 | |||
LICAT ratios (at period end)(4) | |||||
130 % | 145 % | ||||
Sun Life Assurance(5) | 127 % | 124 % | |||
Financial leverage ratio (at period end)(1)(6) | 25.1 % | 25.5 % |
___________ | |
(1) | Represents a non-IFRS financial measure. For more details, see the Non-IFRS Financial Measures section in this document and in our MD&A for the period ended |
(2) | All earnings per share ("EPS") measures refer to fully diluted EPS, unless otherwise stated. |
(3) | AUM is comprised of General Funds and Segregated Funds on our Statements of Financial Position, and other third-party assets managed by the Company ("other AUM"). For more details, see the Non-IFRS Financial Measures section in this document and in our 2022 Annual MD&A. |
(4) | For further information on the Life Insurance Capital Adequacy Test ("LICAT"), see section E - Financial Strength in this document. Our LICAT ratios are calculated in accordance with OSFI-mandated guideline, Life Insurance Capital Adequacy Test. |
(5) | |
(6) | For 2021, amount included |
Financial and Operational Highlights - Quarterly Comparison (Q4'22 vs. Q4'21)
Our strategy is focused on key business segments, where we aim to be a leader in the markets in which we operate.
($ millions, unless otherwise noted) | ||||||||||||
Reported net income (loss)- | Underlying net income (loss)(1) | Insurance sales(1) | Wealth sales and asset | |||||||||
Q4'22 | Q4'21 | change | Q4'22 | Q4'21 | change | Q4'22 | Q4'21 | change | Q4'22 | Q4'21 | change | |
367 | 356 | 3 % | 324 | 266 | 22 % | 246 | 241 | 2 % | 6,584 | 5,676 | 16 % | |
110 | 85 | 29 % | 240 | 72 | 233 % | 1,221 | 1,020 | 20 % | — | — | — | |
Asset Management | 322 | 140 | 130 % | 313 | 382 | (18) % | — | — | — | 37,380 | 46,986 | (20) % |
98 | 446 | (78) % | 152 | 130 | 17 % | 376 | 345 | 9 % | 1,790 | 4,046 | (56) % | |
Corporate | 54 | 51 | nm(2) | (39) | 48 | nm(2) | — | — | — | — | — | — |
Total | 951 | 1,078 | (12) % | 990 | 898 | 10 % | 1,843 | 1,606 | 15 % | 45,754 | 56,708 | (19) % |
(1) | Represents a non-IFRS financial measure. See the Non-IFRS Financial Measures section in this document and in the 2022 Annual MD&A. |
(2) | Not meaningful. |
Reported net income of
Underlying net income of
Reported ROE was
In 2022, Sun Life was certified as a
Underlying net income of
We continue to provide innovative solutions and make it easier for Clients to do business with us. In Q4'22, we published two data driven insight reports for plan sponsors, highlighting how they can better support employees to live healthier lives. These reports offer an in-depth analysis from over 1.5 million plan members, identifying potential health risks and trends. This delivers on our commitment to develop solutions for Clients to take action on their health journey, including our Mental Health Coach, Stress Management and Well-being product, Lumino Health Virtual Care. Also, aligned with our Purpose to help Canadians achieve lifetime financial security, in wealth, we continued to digitize our sponsor base, streamlining their experience and allowing members to leverage digital resources to manage their wealth journey. Digitally active members have higher account balances, higher contributions and are more likely to consolidate their assets with us.
__________ | |
(1) | On |
(2) | |
(3) | Assumption changes and management actions ("ACMA"). |
(4) | Reflects the changes in estimated future payments for acquisition-related contingent considerations and options to purchase remaining ownership interests of SLC Management affiliates. |
(5) | Refer to section C - Profitability in this document for more information about experience-related items and to section G - Non-IFRS Financial Measures for a reconciliation between reported net income and underlying net income. |
(6) | Pensions & Investments, a global news source of money management. |
(7) | Defined contribution sales include retained business sales. |
Underlying net income of
Foreign exchange translation led to an increase of
Supporting our strategic priority of helping Clients access the health care and obtain the coverage they need, DentaQuest expanded its Advantage Dental+ care practices with four new dental offices in
In addition, we continue to make it easier for Clients to do business with us as we expand our digital connectivity capabilities through Application Programming Interfaces ("API"), which alleviate manual administrative tasks, automate processes, improve accuracy and provide real-time updates. For example, we've made it easier to apply for life insurance through this new digital functionality, and members now complete the process online
Asset Management: A global leader in both public and alternative asset classes through MFS and SLC Management
Asset Management reported net income of
Underlying net income of
Foreign exchange translation led to an increase of
Asset Management ended Q4'22 with
MFS maintained a leading position within the
SLC Management is continuing to progress on its climate commitments with a focus on setting interim targets towards net zero greenhouse gas ("GHG") emissions by 2050. In Q4'22,
___________ | |
(1) | Dental sales include sales from DentaQuest, acquired on |
(2) | Reflects the changes in estimated future payments for acquisition-related contingent considerations and options to purchase remaining ownership interests of SLC Management affiliates. |
(3) | According to ISS Market Intelligence Simfund. |
(4) | Represents a non-IFRS financial measure. For more details, see the Non-IFRS Financial Measures section in this document and in the 2022 Annual MD&A. |
(5) | An international group of asset managers committed to supporting the goal of achieving net zero greenhouse gas emissions by 2050 or sooner. |
(6) | In-scope assets comprise approximately |
(7) | Aligning towards or aligned to a net zero pathway as defined by criteria set out in the Net Zero Investment Framework. Criteria are asset class-specific. Pathways is the term used to describe the emissions, technologies and investment trajectories that will be needed to deliver net zero. (Paris Aligned Investment Initiative. "Net Zero Investment Framework: Implementation Guide". 2021). |
Underlying net income of
Foreign exchange translation led to an increase of
We continue to deliver on our distribution excellence strategy. In Vietnam, we achieved breakthrough performance by leveraging our bancassurance partnerships and building a professional advisor team with a focus on providing quality and holistic services to fit our Clients' needs, driving strong growth in our agency channel. Building on the foundation for sustainable and profitable growth in Sun Life Asia, in
In
Corporate
Corporate reported net income of
Underlying net loss was
__________ | |
(1) | |
(2) | Based on |
(3) | Tax related matters include tax-exempt investment income in reported net income and the impact of the Canada Tax Rate Change. On |
IFRS 17 Insurance Contracts ("IFRS 17") and IFRS 9 Financial Instruments ("IFRS 9") to be Adopted in 2023
For periods beginning on or after
The adoption of IFRS 17 and IFRS 9 is not expected to have a material impact on our overall business strategies. However, upon transition at
- A net transfer of
from Shareholders' equity, primarily driven by the establishment of the contractual service margin ("CSM") on the balance sheet, among other items.$4.5 billion - A high single digit decrease(1) in 2022 underlying net income as we restate the comparative year.
On
Our medium-term financial objectives(3), following the adoption of IFRS 17 and 9 as at
- Underlying EPS growth: 8
-10% - Underlying ROE:
18% + (an increase from16% + under IFRS 4) - Underlying Dividend payout ratio: 40
-50%
We continue to assess the impact that the adoption of IFRS 17 and IFRS 9 will have on our Consolidated Financial Statements and estimates of the financial impacts are subject to change. For additional details, refer to Note 2 in the 2022 Consolidated Financial Statements for the period ended December 31, 2022.
__________ | |
(1) | The amount can be impacted by changes in certain experience-related items that are dependent on economic and/or operating environment factors. This statement is a forward-looking statement within the meaning of applicable securities laws. For more information, see the Forward-looking statements section in this document. |
(2) | This statement is a forward-looking statement within the meaning of applicable securities laws. For more information, see the Forward-looking statements section in this document. |
(3) | Although considered reasonable, we may not be able to achieve our medium-term financial objectives as our assumptions may prove to be inaccurate. Accordingly, our actual results could differ materially from our medium-term financial objectives as described above. Our medium-term financial objectives do not constitute guidance. Our medium-term financial objectives are forward-looking non-IFRS financial measures and additional information is provided in the 2022 Annual MD&A in section O - Forward-looking Statements. |
Table of Contents | |||
A. | How We Report Our Results............................................................................................................................................................................................. | 7 | |
B. | Financial Summary............................................................................................................................................................................................................ | 8 | |
C. | Profitability......................................................................................................................................................................................................................... | 9 | |
D. | Growth............................................................................................................................................................................................................................... | 11 | |
E. | Financial Strength............................................................................................................................................................................................................. | 13 | |
F. | Performance by Business Segment.................................................................................................................................................................................. | 15 | |
1. | 15 | ||
2 | 16 | ||
3. | Asset Management........................................................................................................................................................................................................... | 18 | |
4. | 19 | ||
5. | Corporate.......................................................................................................................................................................................................................... | 20 | |
G. | Non-IFRS Financial Measures.......................................................................................................................................................................................... | 21 | |
H. | Forward-looking Statements............................................................................................................................................................................................. | 30 | |
About Sun Life
Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including
A. How We Report Our Results
The information in this document is in Canadian dollars unless otherwise noted.
1. Use of Non-IFRS Financial Measures
We report certain financial information using non-IFRS financial measures, as we believe that these measures provide information that is useful to investors in understanding our performance and facilitate a comparison of our quarterly and full year results from period to period. These non-IFRS financial measures do not have any standardized meaning and may not be comparable with similar measures used by other companies. For certain non-IFRS financial measures, there are no directly comparable amounts under IFRS. These non-IFRS financial measures should not be viewed in isolation from or as alternatives to measures of financial performance determined in accordance with IFRS. Additional information concerning these non-IFRS financial measures and, if applicable, reconciliations to the closest IFRS measures are available in section G - Non-IFRS Financial Measures in this document, and also in our 2022 Annual MD&A and the Supplementary Financial Information package that are available on www.sunlife.com under Investors - Financial results & reports.
2. Forward-looking Statements
Certain statements in this document are forward-looking statements within the meaning of certain securities laws, including the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Additional information concerning forward-looking statements and important risk factors that could cause our assumptions, estimates, expectations and projections to be inaccurate and our actual results or events to differ materially from those expressed in or implied by such forward-looking statements can be found in section H - Forward-looking Statements in this document.
3. Additional Information
Additional information about
4. COVID-19 Pandemic Considerations
In early 2020, the world was impacted by COVID-19, which was declared a pandemic by the
For additional information, refer to section J - Risk Management - 9 - Risks relating to the COVID-19 pandemic in the 2022 Annual MD&A.
B. Financial Summary
($ millions, unless otherwise noted) | Quarterly results | Year-to-date | ||||
Profitability | Q4'22 | Q3'22 | Q4'21 | 2022 | 2021 | |
Net income (loss) | ||||||
Reported net income (loss) - Common shareholders | 951 | 466 | 1,078 | 3,060 | 3,934 | |
Underlying net income (loss)(1) | 990 | 949 | 898 | 3,674 | 3,533 | |
Diluted earnings per share ($) | ||||||
Reported EPS (diluted) | 1.62 | 0.80 | 1.83 | 5.21 | 6.69 | |
Underlying EPS (diluted)(1) | 1.69 | 1.62 | 1.53 | 6.27 | 6.03 | |
Reported basic EPS ($) | 1.62 | 0.80 | 1.84 | 5.22 | 6.72 | |
Return on equity (%) | ||||||
Reported ROE(1) | 15.1 % | 7.6 % | 18.0 % | 12.5 % | 17.1 % | |
Underlying ROE(1) | 15.7 % | 15.5 % | 15.0 % | 15.1 % | 15.4 % | |
Growth | Q4'22 | Q3'22 | Q4'21 | 2022 | 2021 | |
Sales | ||||||
Insurance sales(1) | 1,843 | 943 | 1,606 | 4,321 | 3,674 | |
Wealth sales(1) | 45,754 | 43,096 | 56,708 | 204,113 | 228,408 | |
Value of new business(1) | 468 | 256 | 494 | 1,253 | 1,346 | |
Assets under management(1) | ||||||
General fund assets | 205,614 | 203,567 | 205,374 | |||
Segregated funds | 125,292 | 118,564 | 139,996 | |||
Mutual funds, managed funds and other AUM(1) | 994,953 | 952,624 | 1,099,358 | |||
Total AUM(1) | 1,325,859 | 1,274,755 | 1,444,728 | |||
Financial Strength | Q4'22 | Q3'22 | Q4'21 | |||
LICAT ratios(2) | ||||||
130 % | 129 % | 145 % | ||||
Sun Life Assurance(3) | 127 % | 123 % | 124 % | |||
Financial leverage ratio(1)(4) | 25.1 % | 26.4 % | 25.5 % | |||
Dividend | ||||||
Dividend payout ratio(1) | 43 % | 43 % | 43 % | |||
Dividends per common share ($) | 0.720 | 0.690 | 0.660 | |||
Capital | ||||||
Subordinated debt(4) | 6,676 | 7,075 | 6,425 | |||
Innovative capital instruments(5) | 200 | 200 | 200 | |||
Participating policyholders' equity | 1,837 | 1,764 | 1,700 | |||
Non-controlling interest equity | 90 | 64 | 59 | |||
Preferred shares and other equity instruments | 2,239 | 2,239 | 2,239 | |||
Common shareholders' equity(6) | 25,211 | 24,718 | 24,075 | |||
Total capital(4) | 36,253 | 36,060 | 34,698 | |||
Weighted average common shares outstanding for basic EPS (millions) | 586 | 586 | 586 | |||
Closing common shares outstanding (millions) | 586 | 586 | 586 |
(1) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
(2) | Life Insurance Capital Adequacy Test ("LICAT") ratio. Our LICAT ratios are calculated in accordance with OSFI-mandated guideline, Life Insurance Capital Adequacy Test. |
(3) | |
(4) | For 2021, amount included |
(5) | Innovative capital instruments consist of |
(6) | Common shareholders' equity is equal to Total shareholders' equity less Preferred shares and other equity instruments. |
C. Profitability
The following table reconciles our Common Shareholders' reported net income ("reported net income") and underlying net income. The table also sets out the impacts that other notable items had on reported net income and underlying net income. All factors discussed in this document that impact underlying net income are also applicable to reported net income.
Quarterly results | |||
($ millions, after-tax) | Q4'22 | Q3'22 | Q4'21 |
Reported net income - Common shareholders | 951 | 466 | 1,078 |
Less: Market-related impacts(1) | (136) | (160) | 156 |
Assumption changes and management actions(1) | 54 | 7 | (19) |
Other adjustments(1)(2) | 43 | (330) | 43 |
Underlying net income(3) | 990 | 949 | 898 |
Reported ROE(3) | 15.1 % | 7.6 % | 18.0 % |
Underlying ROE(3) | 15.7 % | 15.5 % | 15.0 % |
Experience-related items attributable to reported net income and underlying net income(3)(4) | |||
Impacts of investment activity on insurance contract liabilities ("investing activity") | 59 | 63 | 14 |
Credit | 18 | 22 | 32 |
Mortality | (47) | 10 | (71) |
Morbidity | 92 | 36 | (34) |
Lapse and other policyholder behaviour ("policyholder behaviour") | (2) | (4) | (10) |
Expenses | (28) | 5 | (47) |
Other experience | (4) | (10) | (1) |
Total of experience-related(3)(4) | 88 | 122 | (117) |
(1) | Represents an adjustment made to arrive at a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document for a breakdown of components within this adjustment, including pre-tax amounts. |
(2) | Other adjustments to arrive at a non-IFRS financial measure include other items that are unusual or exceptional in nature. For more details, see the Non-IFRS Financial Measures section in this document and in our 2022 Annual MD&A. |
(3) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
(4) | Experience-related items reflect the difference between actual experience during the reporting period and best estimate assumptions used in the determination of our insurance contract liabilities. Experience-related items are a part of the Sources of Earnings framework, and are calculated in accordance with OSFI Guideline D-9, Sources of Earnings Disclosures. Experience-related items from our |
Quarterly Comparison - Q4'22 vs. Q4'21
Reported net income of
Underlying net income of
Foreign exchange translation led to an increase of
Reported ROE was
1. Market-related impacts
Market-related impacts resulted in a decrease of
2. Assumption changes and management actions
The net impact of assumption changes and management actions was an increase of
___________ | |
(1) | On |
(2) | Reflects the changes in estimated future payments for acquisition-related contingent considerations and options to purchase remaining ownership interests of SLC Management affiliates. |
3. Other adjustments
Other adjustments increased reported net income by
4. Experience-related items
The notable experience-related items, which impact Q4'22 reported and underlying net income, are as follows:
- Favourable investing activity gains across the businesses;
- Favourable credit experience across the businesses;
- Unfavourable mortality largely from the
U.S. ; - Favourable morbidity experience from the
U.S. andCanada ; and - Unfavourable expense experience from the
U.S. andCanada .
5. Income taxes
The effective tax rate is normally impacted by various tax benefits, such as lower taxes on income subject to tax in foreign jurisdictions, a range of tax-exempt investment income, and other sustainable tax benefits.
On
The Q4'22 effective income tax/(income tax recovery) rates(2) on reported net income and underlying net income(2) were (1.0)% and
6. Impacts of foreign exchange translation
The impacts of foreign exchange translation led to an increase of
__________ | |
(1) | On |
(2) | Our effective income tax rate on reported net income is calculated using Total income (loss) before income taxes, as detailed in Note 20 in our Consolidated Financial Statements for the period ended |
D. Growth
1. Sales and Value of New Business
Quarterly results | |||
($ millions) | Q4'22 | Q3'22 | Q4'21 |
Insurance sales by business segment(1) | |||
246 | 233 | 241 | |
1,221 | 366 | 1,020 | |
376 | 344 | 345 | |
Total insurance sales(1) | 1,843 | 943 | 1,606 |
Wealth sales by business segment(1) | |||
6,584 | 4,131 | 5,676 | |
1,790 | 2,531 | 4,046 | |
Total wealth sales excluding Asset Management | 8,374 | 6,662 | 9,722 |
Asset Management gross flows(1) | 37,380 | 36,434 | 46,986 |
Total wealth sales | 45,754 | 43,096 | 56,708 |
Value of New Business(1) | 468 | 256 | 494 |
(1) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
Total insurance sales increased
Canada insurance sales increased2% , as higher large case group benefits sales inSun Life Health were mostly offset by lower individual participating whole life insurance sales.U.S. insurance sales increased11% (1), driven by higher dental(2) and employee benefits sales, partially offset by lower medical stop-loss sales.Asia insurance sales increased9% (1), driven by sales growth inIndia , International,the Philippines andVietnam , partially offset by lower sales inChina andHong Kong .
Total wealth sales and asset management gross flows decreased
Canada wealth sales increased16% , driven by higher defined contribution(3) sales in GRS, partially offset by lower individual wealth sales.Asia wealth sales decreased56% (1), reflecting lower sales inthe Philippines ,India andHong Kong .- Asset Management gross flows decreased
26% (1), reflecting lower institutional gross flows in SLC Management and lower institutional and retail gross flows in MFS.
Total Company VNB of
__________ | |
(1) | This percentage change excludes the impacts of foreign exchange translation. For more information about these non-IFRS financial measures, see section G - Non-IFRS Financial Measures in this document. |
(2) | Dental sales include sales from DentaQuest, acquired on |
(3) | Defined contribution sales include retained business sales. |
2. Assets Under Management
AUM consists of general funds, the investments for segregated fund holders ("segregated funds") and other AUM, which is comprised of other third-party assets managed by the Company.
Quarterly results | |||||
($ millions) | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
Assets under management(1) | |||||
General fund assets | 205,614 | 203,567 | 195,382 | 196,685 | 205,374 |
Segregated funds | 125,292 | 118,564 | 120,098 | 133,496 | 139,996 |
Other assets under management(1) | |||||
Retail(2)(3) | 527,617 | 505,679 | 508,214 | 568,678 | 623,611 |
Institutional and managed funds(2)(3) | 507,673 | 485,670 | 475,394 | 492,980 | 517,591 |
Consolidation adjustments and other | (40,337) | (38,725) | (38,054) | (39,686) | (41,844) |
Total other AUM(1) | 994,953 | 952,624 | 945,554 | 1,021,972 | 1,099,358 |
Total assets under management(1) | 1,325,859 | 1,274,755 | 1,261,034 | 1,352,153 | 1,444,728 |
(1) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
(2) | Effective |
(3) | Effective |
AUM decreased
(i) unfavourable market movements on the value of segregated, retail, institutional and managed funds of
(ii) net outflows from segregated, retail, institutional and managed funds of
(iii) Client distributions of
(iv) an increase of
(v) an increase of
Segregated, retail, institutional and managed fund net outflows of
Retail, Institutional and managed funds and other AUM decreased by
(i) unfavourable market movements of
(ii) net outflows of
(iii) Client distributions of
(iv) foreign exchange translation of
(v) other business activities of
E. Financial Strength
Quarterly results | |||||
($ millions, unless otherwise stated) | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
LICAT ratio(1) | |||||
130 % | 129 % | 128 % | 143 % | 145 % | |
Sun Life Assurance | 127 % | 123 % | 124 % | 123 % | 124 % |
Financial leverage ratio(2)(3) | 25.1 % | 26.4 % | 25.7 % | 25.9 % | 25.5 % |
Dividend | |||||
Underlying dividend payout ratio(2) | 43 % | 43 % | 45 % | 46 % | 43 % |
Dividends per common share ($) | 0.720 | 0.690 | 0.690 | 0.660 | 0.660 |
Capital | |||||
Subordinated debt(3) | 6,676 | 7,075 | 6,427 | 6,426 | 6,425 |
Innovative capital instruments(4) | 200 | 200 | 200 | 200 | 200 |
Participating policyholders' equity | 1,837 | 1,764 | 1,713 | 1,704 | 1,700 |
Non-controlling interests | 90 | 64 | 56 | 62 | 59 |
Preferred shares and other equity instruments | 2,239 | 2,239 | 2,239 | 2,239 | 2,239 |
Common shareholders' equity(5) | 25,211 | 24,718 | 23,825 | 23,659 | 24,075 |
Total capital(3) | 36,253 | 36,060 | 34,460 | 34,290 | 34,698 |
(1) | Our LICAT ratios are calculated in accordance with OSFI-mandated guideline, Life Insurance Capital Adequacy Test. |
(2) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
(3) | For Q1'22 and Q4'21, amounts included |
(4) | Innovative capital instruments consist of SLEECS and qualify as regulatory capital. However, under IFRS they are reported as Senior debentures in our Consolidated Financial Statements. For additional information, see section I - Capital and Liquidity Management - 1 - Capital in our 2022 Annual MD&A. |
(5) | Common shareholders' equity is equal to Total shareholders' equity less Preferred shares and other equity instruments. |
Life Insurance Capital Adequacy Test
The Office of the Superintendent
Sun Life Assurance,
The Sun Life Assurance LICAT ratio at the end of 2022 and 2021 was well above OSFI's supervisory ratio of
Capital
Our total capital consists of subordinated debt and other capital instruments, participating policyholders' equity and total shareholders' equity which includes common shareholders' equity, preferred shares and other equity instruments, and non-controlling interests. As at
Our capital and liquidity positions remain strong with a LICAT ratio of
___________ | |
(1) | This is a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
(2) | For 2021, amount included |
Capital Transactions
On
On
During the fourth quarter, a matter related to reinsurance pricing for our
Subsequent Events
For additional information, refer to Note 28 of our 2022 Annual Consolidated Financial Statements.
On
On
On
___________ | |
(1) | On a fully diluted basis. |
F. Performance by Business Segment
Quarterly results | |||
($ millions) | Q4'22 | Q3'22 | Q4'21 |
Reported net income (loss) - Common shareholders | |||
367 | 210 | 356 | |
110 | 94 | 85 | |
Asset Management | 322 | 215 | 140 |
98 | 125 | 446 | |
Corporate | 54 | (178) | 51 |
Total reported net income (loss) - Common shareholders | 951 | 466 | 1,078 |
Underlying net income (loss)(1) | |||
324 | 300 | 266 | |
240 | 216 | 72 | |
Asset Management | 313 | 295 | 382 |
152 | 175 | 130 | |
Corporate | (39) | (37) | 48 |
Total underlying net income (loss)(1) | 990 | 949 | 898 |
(1) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
Information describing the business groups and their respective business units is included in our 2022 Annual MD&A. All factors discussed in this document that impact our underlying net income are also applicable to reported net income.
1.
Quarterly results | |||
($ millions) | Q4'22 | Q3'22 | Q4'21 |
165 | 48 | 217 | |
127 | 56 | 65 | |
Group Retirement Services | 75 | 106 | 74 |
Reported net income - Common shareholders | 367 | 210 | 356 |
Less: Market-related impacts(2) | (44) | (134) | 90 |
Assumption changes and management actions(2) | 34 | 45 | 2 |
Acquisition, integration and restructuring(2) | (1) | (1) | (2) |
Other(2)(3) | 54 | — | — |
Underlying net income(4) | 324 | 300 | 266 |
Reported ROE (%)(4) | 16.7 % | 10.1 % | 17.5 % |
Underlying ROE (%)(4) | 14.8 % | 14.3 % | 13.1 % |
Insurance sales(4) | 246 | 233 | 241 |
Wealth sales(4) | 6,584 | 4,131 | 5,676 |
(1) | Effective Q4'21, we began reporting on the performance and results of |
(2) | Represents an adjustment to arrive at a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document for a breakdown of components within this adjustment. |
(3) | Other adjustments to arrive at a non-IFRS financial measure include other items that are unusual or exceptional in nature. See section G - Non-IFRS Financial Measures in this document. |
(4) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
Profitability
Quarterly Comparison - Q4'22 vs. Q4'21
__________ | |
(1) | On |
Underlying net income of
Growth
Quarterly Comparison - Q4'22 vs. Q4'21
2.
Quarterly results | |||
(US$ millions) | Q4'22 | Q3'22 | Q4'21 |
Group Benefits(1) | 110 | 92 | 6 |
Dental(1) | (22) | 9 | 3 |
In-force Management | (7) | (29) | 59 |
Reported net income (loss) - Common shareholders | 81 | 72 | 68 |
Less: Market-related impacts(2) | (46) | (14) | 33 |
Assumption changes and management actions(2) | 2 | (20) | (15) |
Acquisition, integration and restructuring(2) | (55) | (18) | (6) |
Other(2)(3) | 3 | (42) | — |
Underlying net income (loss)(4) | 177 | 166 | 56 |
Reported ROE (%)(4) | 6.2 % | 5.5 % | 8.9 % |
Underlying ROE (%)(4) | 13.6 % | 12.8 % | 7.3 % |
After-tax profit margin for Group Benefits (%)(1)(4)(5) | 8.4 % | 5.9 % | 6.0 % |
Insurance sales(4) | 899 | 281 | 809 |
(C$ millions) | |||
Reported net income (loss) - Common shareholders | 110 | 94 | 85 |
Less: Market-related impacts(2) | (63) | (17) | 40 |
Assumption changes and management actions(2) | 3 | (26) | (19) |
Acquisition, integration and restructuring(2) | (74) | (24) | (8) |
Other(2)(3) | 4 | (55) | — |
Underlying net income (loss)(4) | 240 | 216 | 72 |
(1) | Effective Q2'22, we began reporting on the performance and results of our Dental business unit, which represents our existing dental and vision business within Group Benefits together with |
(2) | Represents an adjustment made to arrive at a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document for a breakdown of components within this adjustment, including pre-tax amounts. |
(3) | Other adjustments to arrive at a non-IFRS financial measure include other items that are unusual or exceptional in nature. See section G - Non-IFRS Financial Measures in this document. |
(4) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
(5) | Based on underlying net income, on a trailing four-quarter basis, and which is described in section G - Non-IFRS Financial Measures in this document. |
Profitability
Quarterly Comparison - Q4'22 vs. Q4'21
Underlying net income of
Foreign exchange translation led to an increase of
_____________ | |
(1) | Defined contribution sales include retained business sales. |
Growth
Quarterly Comparison - Q4'22 vs. Q4'21
____________ | |
(1) | Dental sales include sales from DentaQuest, acquired on |
3. Asset Management
Quarterly results | |||
Asset Management (C$ millions) | Q4'22 | Q3'22 | Q4'21 |
Reported net income - Common shareholders | 322 | 215 | 140 |
Less: Fair value adjustments on MFS's share-based payment awards(1) | 28 | 37 | (47) |
Acquisition, integration and restructuring(1)(2)(3) | (26) | (117) | (195) |
Other(1)(4) | 7 | — | — |
Underlying net income(5) | 313 | 295 | 382 |
Assets under management (C$ billions)(5) | 952.0 | 911.6 | 1,059.2 |
Gross flows (C$ billions)(5) | 37.4 | 36.4 | 47.0 |
Net flows (C$ billions)(5) | (12.6) | (7.7) | 8.3 |
MFS (C$ millions) | |||
Reported net income - Common shareholders | 303 | 312 | 295 |
Less: Fair value adjustments on MFS's share-based payment awards(1) | 28 | 37 | (47) |
Underlying net income(5) | 275 | 275 | 342 |
Assets under management (C$ billions)(5) | 742.3 | 703.4 | 875.2 |
Gross flows (C$ billions)(5) | 31.2 | 28.2 | 34.9 |
Net flows (C$ billions)(5) | (16.1) | (13.4) | (1.5) |
MFS (US$ millions) | |||
Reported net income - Common shareholders | 223 | 240 | 234 |
Less: Fair value adjustments on MFS's share-based payment awards(1) | 21 | 28 | (38) |
Underlying net income(5) | 202 | 212 | 272 |
Pre-tax net operating profit margin for MFS(5) | 40 % | 41 % | 43 % |
Average net assets (US$ billions)(5) | 540.5 | 560.9 | 680.6 |
Assets under management (US$ billions)(5)(6) | 547.9 | 508.7 | 692.8 |
Gross flows (US$ billions)(5) | 23.0 | 21.6 | 27.7 |
Net flows (US$ billions)(5) | (11.9) | (10.3) | (1.2) |
Asset appreciation (depreciation) (US$ billions) | 51.0 | (33.9) | 36.9 |
SLC Management (C$ millions) | |||
Reported net income - Common shareholders | 19 | (97) | (155) |
Less: Acquisition, integration and restructuring(1)(2)(3) | (26) | (117) | (195) |
Other(1)(4) | 7 | — | — |
Underlying net income(5) | 38 | 20 | 40 |
Fee-related earnings(5) | 73 | 58 | 60 |
Pre-tax fee-related earnings margin(5)(7) | 24 % | 24 % | 22 % |
Pre-tax net operating margin(5)(7) | 21 % | 22 % | 22 % |
Assets under management (C$ billions)(5) | 209.6 | 208.2 | 183.9 |
Gross flows (C$ billions)(5) | 6.1 | 8.2 | 12.1 |
Net flows (C$ billions)(5) | 3.5 | 5.7 | 9.7 |
Fee earning assets under management ("FE AUM") (C$ billions)(5) | 164.4 | 162.9 | 147.9 |
Gross flows - | 7.9 | 10.2 | 13.5 |
Net flows - | 5.8 | 8.8 | 11.5 |
Capital raising (C$ billions)(5) | 3.0 | 3.8 | 6.6 |
Deployment (C$ billions)(5) | 6.9 | 9.5 | 10.9 |
(1) | Represents an adjustment made to arrive at a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document for a breakdown of components within this adjustment, including pre-tax adjustments. |
(2) | Amounts relate to acquisition costs for our SLC Management affiliates, BentallGreenOak, |
(3) | Reflects the changes in estimated future payments for acquisition-related contingent considerations and options to purchase remaining ownership interests of SLC Management affiliates of |
(4) | Other adjustments to arrive at a non-IFRS financial measure include other items that are unusual or exceptional in nature. See section G - Non-IFRS Financial Measures in this document. |
(5) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
(6) | Monthly information on AUM is provided by MFS in its Corporate Fact Sheet, which can be found at www.mfs.com/CorpFact. The Corporate Fact Sheet also provides MFS's |
(7) | Based on a trailing 12-month basis. |
Profitability
Quarterly Comparison - Q4'22 vs. Q4'21
Asset Management's reported net income of
Underlying net income of
Foreign exchange translation led to an increase of
MFS' Q4'22 reported net income of
SLC Management's reported net income was
Growth
Asset Management's AUM decreased
MFS's AUM decreased
SLC Management's AUM increased by
SLC Management
In the fourth quarter of 2022, SLC Management reported net inflows of
4.
Quarterly results | |||
($ millions) | Q4'22 | Q3'22 | Q4'21 |
Local Markets | 36 | 52 | 374 |
International Hubs | 62 | 73 | 72 |
Reported net income - Common shareholders | 98 | 125 | 446 |
Less: Market-related impacts(1) | (88) | 8 | 23 |
Assumption changes and management actions(1) | 17 | (58) | (2) |
Acquisition, integration and restructuring(1) | — | — | 295 |
Other(1)(2) | 17 | — | — |
Underlying net income (loss)(3) | 152 | 175 | 130 |
Reported ROE (%)(3) | 5.5 % | 7.3 % | 27.7 % |
Underlying ROE (%)(3) | 8.6 % | 10.2 % | 8.0 % |
Insurance sales(3) | 376 | 344 | 345 |
Wealth sales(3) | 1,790 | 2,531 | 4,046 |
(1) | Represents an adjustment made to arrive at a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document for a breakdown of components within this adjustment, including pre-tax amounts. |
(2) | Other adjustments to arrive at a non-IFRS financial measure include other items that are unusual or exceptional in nature. See section G - Non-IFRS Financial Measures in this document. |
(3) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
__________ | |
(1) | Reflects the changes in estimated future payments for acquisition-related contingent considerations and options to purchase remaining ownership interests of SLC Management affiliates. |
Profitability
Quarterly Comparison - Q4'22 vs. Q4'21
Underlying net income of
Foreign exchange translation led to an increase of
Growth
Quarterly Comparison - Q4'22 vs. Q4'21
5. Corporate
Quarterly results | |||
($ millions) | Q4'22 | Q3'22 | Q4'21 |
15 | (107) | 23 | |
Corporate Support | 39 | (71) | 28 |
Reported net income (loss) - Common shareholders | 54 | (178) | 51 |
Less: Market-related impacts(1) | 59 | (17) | 3 |
Assumption changes and management actions(1) | — | 46 | — |
Other(1)(2) | 34 | (170) | — |
Underlying net income (loss)(3) | (39) | (37) | 48 |
(1) | Represents an adjustment made to arrive at a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document for a breakdown of components within this adjustment, including pre-tax amounts. |
(2) | Other adjustments to arrive at a non-IFRS financial measure include other items that are unusual or exceptional in nature. See section G - Non-IFRS Financial Measures in this document. |
(3) | Represents a non-IFRS financial measure. See section G - Non-IFRS Financial Measures in this document. |
Profitability
Quarterly Comparison - Q4'22 vs. Q4'21
Corporate reported net income of
Underlying net loss was
_________ | |
(1) | This percentage change excludes the impacts of foreign exchange translation. For more information about these non-IFRS financial measures, see section G - Non-IFRS Financial Measures in this document. |
(2) | Tax related matters include tax-exempt investment income in reported net income and the impact of the Canada Tax Rate Change. On |
G. Non-IFRS Financial Measures
1. Underlying Net Income and Underlying EPS
Underlying net income (loss) and financial measures based on underlying net income (loss), including underlying EPS or underlying loss per share, and underlying ROE, are non-IFRS financial measures. Underlying net income (loss) removes from reported net income (loss) the impacts of the following items in our results under IFRS and when removed assist in explaining our results from period to period:
(a) market-related impacts that differ from our best estimate, which include: (i) impacts of returns in equity markets, net of hedging, for which our best estimate assumptions are approximately
(b) assumption changes and management actions, which include: (i) the impacts of revisions to the methods and assumptions used in determining our liabilities for insurance contracts and investment contracts; and (ii) the impacts on insurance contracts and investment contracts of actions taken by management in the current reporting period, referred to as management actions which include, for example, changes in the prices of in-force products, new or revised reinsurance on in-force business, and material changes to investment policies for assets supporting our liabilities; and
(c) other adjustments:
i. fair value adjustments on MFS' share-based payment awards that are settled with MFS' own shares and accounted for as liabilities and measured at fair value each reporting period until they are vested, exercised and repurchased - this adjustment enhances the comparability of MFS' results with publicly traded asset managers in
ii. acquisition, integration and restructuring costs - this adjustment enhances comparability of our results from period to period, by removing the impacts of costs, including the unwinding of the discount for certain liabilities related to acquisitions, that are not ongoing in nature and are incurred with the intent to generate benefits in future periods;
iii. certain hedges in
iv. other items that are unusual or exceptional in nature.
All factors discussed in this document that impact our underlying net income are also applicable to reported net income. All EPS measures in this document refer to fully diluted EPS, unless otherwise stated. As noted below, underlying EPS excludes the dilutive impacts of convertible instruments.
Underlying EPS (diluted). This measure is used in comparing the profitability across multiple periods and is calculated by dividing underlying net income by weighted average common shares outstanding for diluted EPS, excluding the dilutive impact of convertible instruments. For additional information about the underlying net income, see above. For additional information about the composition of the EPS, please refer to Note 26 of our 2022 Annual Consolidated Financial Statements. For additional information about the SLEECS, please refer to Note 13 of our 2022 Annual Consolidated Financial Statements.
__________ | |
(1) | The removal of tax-exempt investment income differing from our best estimate has been applied prospectively, effective Q4'22. |
The following table sets out the post-tax amounts that were excluded from our underlying net income (loss) and underlying EPS and provides a reconciliation to our reported net income (loss) and EPS based on IFRS.
Reconciliations of Select Net Income Measures | Quarterly results | Year-to-date | |||
($ millions, unless otherwise noted) | Q4'22 | Q3'22 | Q4'21 | 2022 | 2021 |
Reported net income - Common shareholders | 951 | 466 | 1,078 | 3,060 | 3,934 |
Market-related impacts | |||||
Equity market impacts | |||||
Impacts from equity market changes | (48) | (53) | 97 | (294) | 278 |
Basis risk impacts | 14 | 5 | 10 | 51 | 24 |
Equity market impacts | (34) | (48) | 107 | (243) | 302 |
Interest rate impacts(1) | |||||
Impacts of interest rate changes | (23) | (123) | (35) | (296) | 74 |
Impacts of credit spread movements | (16) | 6 | 3 | 50 | (11) |
Impacts of swap spread movements | 4 | 2 | (4) | (2) | 8 |
Interest rate impacts | (35) | (115) | (36) | (248) | 71 |
Impacts of changes in the fair value of investment properties | (67) | 3 | 85 | 81 | 254 |
Less: Market-related impacts | (136) | (160) | 156 | (410) | 627 |
Less: Assumption changes and management actions | 54 | 7 | (19) | 62 | 74 |
Other adjustments | |||||
Fair value adjustments on MFS' share-based payment awards | 28 | 37 | (47) | 106 | (186) |
Acquisition, integration and restructuring(2)(3)(4)(5)(6) | (101) | (142) | 90 | (338) | (18) |
Other(7)(8)(9)(10)(11)(12)(13) | 116 | (225) | — | (34) | (96) |
Less: Total of other adjustments | 43 | (330) | 43 | (266) | (300) |
Underlying net income | 990 | 949 | 898 | 3,674 | 3,533 |
Reported EPS (diluted) ($) | 1.62 | 0.80 | 1.83 | 5.21 | 6.69 |
Less: Market-related impacts ($) | (0.23) | (0.27) | 0.26 | (0.70) | 1.06 |
Assumption changes and management actions ($) | 0.09 | 0.01 | (0.03) | 0.10 | 0.12 |
Fair value adjustments on MFS' share-based payment awards ($) | 0.05 | 0.06 | (0.08) | 0.18 | (0.32) |
Acquisition, integration and restructuring ($) | (0.18) | (0.24) | 0.15 | (0.56) | (0.03) |
Other ($) | 0.20 | (0.37) | — | (0.06) | (0.16) |
Impact of convertible securities on diluted EPS ($) | — | (0.01) | — | (0.02) | (0.01) |
Underlying EPS (diluted) ($) | 1.69 | 1.62 | 1.53 | 6.27 | 6.03 |
(1) | Our exposure to interest rates varies by product type, line of business, and geography. Given the long-term nature of our business, we have a higher degree of sensitivity in respect of interest rates at long durations. |
(2) | Amounts relate to acquisition costs for our SLC Management affiliates, BentallGreenOak, |
(3) | The restructuring charge of |
(4) | Reflects acquisition and integration costs associated with DentaQuest, acquired on |
(5) | Reflects the changes in estimated future payments for acquisition-related contingent considerations and options to purchase remaining ownership interests of SLC Management affiliates of |
(6) | Reflects a realized gain of |
(7) | Q3'22 reflects an impairment charge of |
(8) | Includes a charge of |
(9) | Q2'22 reflects a gain on the sale-leaseback of our |
(10) | Q3'21 reflects an adjustment for investment income and expense allocations between participating policyholders and shareholders for prior years. |
(11) | Q2'21 reflects the |
(12) | On |
(13) | Q4'22 includes the unwinding of an internal reinsurance agreement. |
The following table shows the pre-tax amount of underlying net income adjustments:
Quarterly results | Year-to-date | ||||
($ millions, unless otherwise noted) | Q4'22 | Q3'22 | Q4'21 | 2022 | 2021 |
Reported net income - Common shareholders (after-tax) | 951 | 466 | 1,078 | 3,060 | 3,934 |
Underlying net income adjustments (pre-tax): | |||||
Less: Market-related impacts | (273) | (212) | 153 | (401) | 849 |
Assumption changes and management actions | 67 | 15 | (23) | 83 | 66 |
Other adjustments(1) | (88) | (362) | 67 | (419) | (320) |
Total underlying net income adjustments (pre-tax) | (294) | (559) | 197 | (737) | 595 |
Less: Taxes related to underlying net income adjustments(1) | 255 | 76 | (17) | 123 | (194) |
Underlying net income (after-tax) | 990 | 949 | 898 | 3,674 | 3,533 |
(1) | Effective |
Taxes related to underlying net income adjustments may vary from the expected effective tax rate range reflecting the mix of business based on the Company's international operations.
2. Additional Non-IFRS Financial Measures
Management also uses the following non-IFRS financial measures:
After-tax profit margin for
Assets under management. AUM is a non-IFRS financial measure that indicates the size of our company's asset management, wealth, and insurance assets. There is no standardized financial measure under IFRS. In addition to the most directly comparable IFRS measures, which are the balance of General funds and Segregated funds on our Statements of Financial Position, AUM also includes Other AUM.
Other AUM is composed of retail, institutional and other-third party assets, as well as general fund and segregated fund assets managed by our joint ventures. In
Effective
Quarterly results | ||
($ millions) | Q4'22 | Q4'21 |
General fund assets | 205,614 | 205,374 |
Segregated funds | 125,292 | 139,996 |
Other AUM | 994,953 | 1,099,358 |
Total assets under management | 1,325,859 | 1,444,728 |
Assumption changes and management actions. In this document the impacts of ACMA on shareholders' net income (after-tax) is included in reported net income and is excluded from underlying net income, as described in section D - Profitability in the 2022 Annual MD&A.
Note 10.A of the Consolidated Financial Statements for the period ended December 31, 2022 shows the pre-tax impacts of method and assumption changes on shareholders' and participating policyholders' insurance contract liabilities net of reinsurance assets, excluding changes in other policy liabilities and assets. The view in this document of ACMA is the impacts on shareholders' reported net income (after-tax). The Consolidated Financial Statements view is a component of the change in total company liabilities.
The following table provides a reconciliation of the differences between the two measures.
Quarterly results | Year-to-date | ||||
($ millions) | Q4'22 | Q3'22 | Q4'21 | 2022 | 2021 |
Impacts of method and assumption changes on insurance contract liabilities (pre-tax) | 69 | (17) | 1 | 57 | (273) |
Less: Participating policyholders(1) | (1) | — | — | 3 | (9) |
Less: Other items(2) | — | (20) | — | (20) | — |
Impacts of method and assumption changes excluding participating policyholders (pre-tax) | 70 | 3 | 1 | 74 | (264) |
Less: Tax | 14 | 5 | — | 19 | (93) |
Impacts of method and assumption changes excluding participating policyholders (after-tax) | 56 | (2) | 1 | 55 | (171) |
Add: Management actions (after-tax)(3) | (2) | 9 | (20) | 7 | 247 |
Other (after-tax)(4) | — | — | — | — | (2) |
Assumption changes and management actions (after-tax)(5)(6) | 54 | 7 | (19) | 62 | 74 |
(1) | Adjustment to remove the pre-tax impacts of method and assumption changes on amounts attributed to participating policyholders. |
(2) | Other includes a charge reflecting the resolution of a matter related to reinsurance pricing for our |
(3) | Adjustment to include the impacts of management actions on insurance contract liabilities and investment contract liabilities which include, for example, changes in the prices of in-force products, new or revised reinsurance on in-force business, and material changes to investment policies for assets supporting our liabilities, on an after-tax basis. The pre-tax impact of management actions to Method and assumption changes on insurance contract liabilities was a decrease of |
(4) | Adjustments to include the impacts of method and assumption changes on investment contracts and other policy liabilities, on an after-tax basis. The pre-tax impact to Method and assumption changes on insurance contract liabilities was $nil in Q4'22 and $nil in 2022 (Q3'22 - $nil; Q4'21 - $nil; 2021 - a decrease of |
(5) | Includes the tax impacts of ACMA on insurance contract liabilities and investment contract liabilities, reflecting the tax rates in the jurisdictions in which we do business. |
(6) | ACMA is included in reported net income and is excluded in calculating underlying net income, as described in section D - Profitability in the 2022 Annual MD&A. |
AUM not yet earning fees. This measure represents the committed uninvested capital portion of total AUM not currently earning management fees. The amount depends on the specific terms and conditions of each fund. There is no directly comparable IFRS measure.
Capital raising. This measure consists of increases in SLC Management's commitments from fund raising activities for all real estate, infrastructure and alternative credit Clients excluding leverage. Investment-grade fixed income capital raising consists of sales made to new Clients. There is no directly comparable IFRS measure.
Cash and other liquid assets. This measure is comprised of cash, cash equivalents, short-term investments, and publicly traded securities, net of loans related to acquisitions that are held at
($ millions) | As at | As at |
Cash, cash equivalents & short-term securities | 423 | 2,383 |
Debt securities(1) | 1,408 | 1,421 |
Equity securities(2) | 102 | 861 |
Sub-total(3) | 1,933 | 4,665 |
Less: Loans related to acquisitions (held at | (883) | — |
Cash and other liquid assets (held at | 1,050 | 4,665 |
(1) | Includes publicly traded bonds. |
(2) | Includes ETF Investments. |
(3) | For 2021, amount included |
(4) | Loans related to acquisitions have been included as an adjustment to Cash and other liquid assets, as they reflect funding for the DentaQuest acquisition. |
(5) | Represents available funds for capital re-deployment. |
Constant currency. We remove the impacts of foreign exchange translation from certain IFRS and non-IFRS measures to assist in comparing our results from period to period. The impacts of foreign exchange translation is approximated by using the foreign exchange rates in effect during the comparative period, using the average or period end foreign exchange rates, as appropriate.
Deployment. This measure represents the amount of capital that has been invested in the period, including leverage where applicable. Deployment also includes capital committed in infrastructure deals to be invested in specific assets. There is no directly comparable IFRS measure.
Earnings on Surplus. This component of the Sources of Earnings ("SOE") represents the net income earned on a company's surplus funds. Earnings on Surplus is comprised of realized gains on available-for-sale assets, as well as net investment returns on surplus, such as investment income, gains (losses) on seed investments, investment properties mark-to-market, and interest on debt.
Expected profit. The portion of the consolidated pre-tax net income on business in-force at the start of the reporting period that was expected to be realized based on the achievement of the best estimate assumptions made at the beginning of the reporting period. Expected profit for asset management companies is set equal to their pre-tax net income.
Experience-related items attributable to reported net income and underlying net income. Pre-tax gains and losses that are due to differences between the actual experience during the reporting period and the best estimate assumptions at the start of the reporting period. Experience-related items are a part of the Sources of Earnings framework, and are calculated in accordance with OSFI Guideline D-9, Sources of Earnings Disclosures.
Fee earning AUM.
Fee-related earnings and Operating income. Fee-related earnings represent profitability of SLC Management's fee-related portfolios, and is calculated as Fee-related revenue less Fee-related expenses. Operating income represents profit realized from our business operations, and is calculated as the sum of Fee-related earnings, Investment income (loss) and performance fees, and Interest and other. Fee-related revenue represents all fee income, with the exception of performance fees, generated from third-party investors. Fee-related expenses represent all expenses directly related to generating fee revenue from third-party investors. Investment income (loss) and performance fees represent total income or loss from our seed investments, net of the related expenses. Interest and other represents performance fee compensation, our net interest income or expense and income from managing the General Account assets.
Fee-related earnings and Operating income are non-IFRS financial measures within SLC Management's Supplemental Income Statement, which enhances the comparability of SLC Management's results with publicly traded alternative asset managers. For more details, see our Supplementary Financial Information package for the quarter.
The following table provides a reconciliation from Fee-related earnings and Operating income to SLC Management's Fee income and Total expenses based on IFRS.
SLC Management | Quarterly results | Year-to-date | |||
($ millions) | Q4'22 | Q3'22 | Q4'21 | 2022 | 2021 |
Fee income (per IFRS) | 501 | 310 | 300 | 1,412 | 1,099 |
Less: Non-fee-related revenue adjustments(1)(2) | 235 | 67 | 59 | 435 | 231 |
Fee-related revenue | 266 | 243 | 241 | 977 | 868 |
Total expenses (per IFRS) | 452 | 391 | 470 | 1,405 | 1,271 |
Less: Non-fee-related expense adjustments(2)(3) | 259 | 206 | 289 | 665 | 600 |
Fee-related expenses | 193 | 185 | 181 | 740 | 671 |
Fee-related earnings | 73 | 58 | 60 | 237 | 197 |
Add: Investment income (loss) and performance fees(4) | 13 | — | 15 | 24 | 34 |
Add: Interest and other(5) | (21) | (16) | (11) | (50) | (35) |
Operating income | 65 | 42 | 64 | 211 | 196 |
(1) | Includes Interest and other - fee income, Investment income (loss) and performance fees - fee income, and Other - fee income. |
(2) | Excludes the income and related expenses for certain property management agreements to provide more accurate metrics on our fee-related business. |
(3) | Includes Interest and other, Placement fees - other, Amortization of intangibles, Acquisition, integration and restructuring, and Other - expenses. |
(4) | Investment income (loss) and performance fee in SLC Management's Supplemental Income Statement relates to our seed investments, and as such, we have excluded the gains or losses of certain non-seed hedges that are reported under Net investment income (loss) under IFRS as follows (amounts have been adjusted for rounding): |
Quarterly results | Year-to-date | ||||
($ millions) | Q4'22 | Q3'22 | Q4'21 | 2022 | 2021 |
Net investment income (loss) (per IFRS) | 5 | (14) | (1) | 1 | 19 |
Less: Other - Investment income (loss) | (3) | (14) | (5) | (15) | (3) |
Add: Investment income (loss) and performance fees - fee income | 5 | — | 11 | 8 | 12 |
Investment income (loss) and performance fees | 13 | — | 15 | 24 | 34 |
(5) | Includes Interest and other reported under Fee income under IFRS, net of Interest and other reported under Total expenses under IFRS. |
Financial leverage ratio. This total debt to total capital ratio is ratio of debt plus preferred shares to total capital, where debt consists of all capital qualifying debt securities. Capital qualifying debt securities consist of subordinated debt and innovative capital instruments. The ratio is an indicator of the Company's capital adequacy measured by its proportion of capital qualifying debt in accordance with OSFI guidelines.
Impacts of foreign exchange translation. To assist in comparing our results from period-to-period, the favourable or unfavourable impacts of foreign exchange translation are approximated using the foreign exchange rates, in effect during the comparative period, for several IFRS and Non-IFRS financial measures using the average or period end foreign exchange rates, as appropriate. Items impacting a reporting period, such as Revenue, Benefits and expenses, and Reported net income (loss) in our Consolidated Statements of Operations, as well as underlying net income (loss), and sales, are translated into Canadian dollars using average exchange rates for the appropriate daily, monthly, or quarterly period. For items as at a point in time, such as Assets and Liabilities in our Consolidated Statements of Financial Position, as well as the AUM and Expected profit component of our Sources of Earnings disclosure, period-end rates are used for currency translation purposes.
Impact of new business. The point-of-sale impact on pre-tax net income of writing new business during the reporting period. Issuing new business may produce a gain or loss at the point-of sale, primarily because valuation assumptions are different than pricing assumptions and/or actual acquisition expenses may differ from those assumed in pricing.
Other AUM. Other AUM is composed of retail, institutional and other-third party assets, as well as general fund and segregated fund assets managed by our joint ventures. In
Effective
Pre-tax fee related earnings margin. This ratio is a measure of SLC Management's profitability in relation to funds that earn recurring fee revenues, while excluding investment income and performance fees. The ratio is calculated by dividing fee-related earnings by fee-related revenues and is based on the last twelve months. There is no directly comparable IFRS measure.
Pre-tax net operating margin. This ratio is a measure of the profitability and there is no directly comparable IFRS measure. For MFS, this ratio is calculated by excluding the impact of fair value adjustments on MFS' share-based payment awards and certain commission expenses that are offsetting. These commission expenses are excluded in order to neutralize the impact these items have on the pre-tax net operating margin and have no impact on the profitability of MFS. For SLC Management, the ratio is calculated by dividing the total operating income by fee-related revenue plus investment Income (loss) and performance fees, and is based on the last twelve months.
Effective
The following table provides a reconciliation to calculate MFS' pre-tax net operating margin:
MFS | Quarterly results | Year-to-date | |||
(US$ millions) | Q4'22 | Q3'22 | Q4'21 | 2022 | 2021 |
Revenue | |||||
Fee income (per IFRS) | 775 | 801 | 981 | 3,323 | 3,779 |
Less: Commissions | 99 | 104 | 131 | 433 | 509 |
Less: Other(1) | (13) | (13) | (10) | (53) | (42) |
Adjusted revenue | 689 | 710 | 860 | 2,943 | 3,312 |
Expenses | |||||
Expenses (per IFRS) | 514 | 500 | 668 | 2,162 | 2,650 |
Net investment (income)/loss (per IFRS) | (22) | (7) | (1) | (17) | — |
Less: Gross fair value adjustments on share-based payment awards(2) | (11) | (17) | 56 | (38) | 216 |
Less: Commissions | 99 | 104 | 131 | 433 | 509 |
Less: Other(1) | (13) | (13) | (10) | (53) | (42) |
Adjusted expenses | 417 | 419 | 490 | 1,803 | 1,967 |
Pre-tax net operating margin | 40 % | 41 % | 43 % | 39 % | 41 % |
(1) | Other includes accounting basis differences, such as sub-advisory expenses and product allowances. |
(2) | For more information on this adjustment made to arrive at a non-IFRS financial measure, see the heading Underlying Net Income and Underlying EPS. |
Return on equity. IFRS does not prescribe the calculation of ROE and therefore a comparable measure under IFRS is not available. To determine reported ROE and underlying ROE, respectively, reported net income (loss) and underlying net income (loss) is divided by the total weighted average common shareholders' equity for the period. The ROE provides an indication of the overall profitability of the Company. The quarterly ROE is annualized.
Sales and gross flows. In Canada, insurance sales consist of sales of individual insurance and
Sources of Earnings ("SOE"). The
Underlying dividend payout ratio. This is the ratio of dividends paid per share to diluted underlying EPS for the period. The ratio is utilized during the capital budgeting process to ensure that we are able to achieve our payout targets after factoring in our planned capital initiatives. We target an underlying dividend payout ratio of between
Underlying effective tax rate. This measure is calculated using the pre-tax underlying net income and the income tax expense associated with it. Our statutory tax rate is normally reduced by various tax benefits, such as lower taxes on income subject to tax in foreign jurisdictions, a range of tax-exempt investment income, and other sustainable tax benefits. Our effective tax rate helps in the analysis of the income tax impacts in the period.
Value of New Business. VNB represents the present value of our best estimate of future distributable earnings, net of the cost of capital, from new business contracts written in a particular time period, except new business in our Asset Management pillar. The assumptions used in the calculations are generally consistent with those used in the valuation of our insurance contract liabilities except that discount rates used approximate theoretical return expectations of an equity investor. Capital required is based on the higher of Sun Life Assurance's LICAT operating target and local (country specific) operating target capital. VNB is a useful metric to evaluate the present value created from new business contracts. There is no directly comparable IFRS measure.
3. Reconciliations of Select Non-IFRS Financial Measures
Reported Net Income to Underlying Net Income Reconciliation - Pre-tax by
Q4'22 | ||||||
($ millions) | Canada | U.S. | Asset Management | Corporate | Total | |
Reported net income (loss) - Common shareholders | 367 | 110 | 322 | 98 | 54 | 951 |
Less: Market-related impacts (pre-tax)(1) | (110) | (79) | — | (87) | 3 | (273) |
ACMA (pre-tax) | 47 | 4 | — | 16 | — | 67 |
Other adjustments (pre-tax)(1)(2) | (1) | (96) | 9 | 17 | (17) | (88) |
Tax expense (benefit) on above items(2) | 107 | 41 | — | — | 107 | 255 |
Underlying net income (loss) | 324 | 240 | 313 | 152 | (39) | 990 |
Q3'22 | ||||||
Reported net income (loss) - Common shareholders | 210 | 94 | 215 | 125 | (178) | 466 |
Less: Market-related impacts (pre-tax)(1) | (170) | (22) | — | 8 | (28) | (212) |
ACMA (pre-tax) | 62 | (33) | — | (58) | 44 | 15 |
Other adjustments (pre-tax)(1)(2) | (1) | (102) | (89) | — | (170) | (362) |
Tax expense (benefit) on above items(2) | 19 | 35 | 9 | — | 13 | 76 |
Underlying net income (loss) | 300 | 216 | 295 | 175 | (37) | 949 |
Q4'21 | ||||||
Reported net income (loss) - Common shareholders | 356 | 85 | 140 | 446 | 51 | 1,078 |
Less: Market-related impacts (pre-tax)(1) | 71 | 51 | — | 29 | 2 | 153 |
ACMA (pre-tax) | 2 | (23) | — | (2) | — | (23) |
Other adjustments (pre-tax)(1)(2) | (3) | (10) | (273) | 353 | — | 67 |
Tax expense (benefit) on above items(2) | 20 | (5) | 31 | (64) | 1 | (17) |
Underlying net income (loss) | 266 | 72 | 382 | 130 | 48 | 898 |
(1) | For a breakdown of this adjustment made to arrive at a non-IFRS financial measure, see the heading Underlying Net Income and Underlying EPS. |
(2) | Effective |
Reported Net Income to Underlying Net Income Reconciliation - Pre-tax by Business Unit - Asset Management
Q4'22 | Q3'22 | Q4'21 | ||||
($ millions) | MFS | SLC Management | MFS | SLC | MFS | SLC Management |
Reported net income (loss) - Common shareholders | 303 | 19 | 312 | (97) | 295 | (155) |
Less: Other adjustments (pre-tax)(1)(2) | 33 | (24) | 42 | (131) | (48) | (225) |
Tax expense (benefit) on above items(2) | (5) | 5 | (5) | 14 | 1 | 30 |
Underlying net income (loss) | 275 | 38 | 275 | 20 | 342 | 40 |
(1) | For a breakdown of this adjustment made to arrive at a non-IFRS financial measure, see the heading Underlying Net Income and Underlying EPS. |
(2) | Effective |
Reported Net Income to Underlying Net Income Reconciliation - Pre-tax in
Q4'22 | Q3'22 | Q4'21 | ||||
(US$ millions) | MFS | MFS | MFS | |||
Reported net income (loss) - Common shareholders | 81 | 223 | 72 | 240 | 68 | 234 |
Less: Market-related impacts (pre-tax)(1) | (58) | — | (18) | — | 42 | — |
ACMA (pre-tax) | 3 | — | (25) | — | (19) | — |
Other adjustments (pre-tax)(1)(2) | (71) | 24 | (78) | 32 | (8) | (39) |
Tax expense (benefit) on above items(2) | 30 | (3) | 27 | (4) | (3) | 1 |
Underlying net income (loss) | 177 | 202 | 166 | 212 | 56 | 272 |
(1) | For a breakdown of this adjustment made to arrive at a non-IFRS financial measure, see the heading Underlying Net Income and Underlying EPS. |
(2) | Effective |
Reported Net Income to Underlying Net Income Reconciliation -
The following table sets out the amounts that were excluded from our underlying net income (loss) for
(US$ millions) | Q4'22 | Q3'22 | Q4'21 |
Reported net income (loss) - Common shareholders(1) | 110 | 92 | 6 |
Less: Market-related impacts (pre-tax)(2) | (5) | (5) | 8 |
ACMA (pre-tax) | — | (8) | — |
Other adjustments (pre-tax)(2) | (1) | (1) | (1) |
Tax expense (benefit) on above items | 1 | 3 | (1) |
Underlying net income (loss) for | 115 | 103 | — |
(1) | Effective Q2'22, we began reporting on the performance and results of our Dental business unit, which represents our existing dental and vision business within Group Benefits together with DentaQuest, acquired on |
(2) | For a breakdown of this adjustment made to arrive at a non-IFRS financial measure, see the heading Underlying Net Income and Underlying EPS. |
H. Forward-looking Statements
From time to time, the Company makes written or oral forward-looking statements within the meaning of certain securities laws, including the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements contained in this document include statements (i) relating to our strategies; (ii) relating to our intention to divest Sun Life
Forward-looking statements are not a guarantee of future performance and involve risks and uncertainties that are difficult to predict. Future results and shareholder value may differ materially from those expressed in these forward-looking statements. In addition, as Sun Life works to advance its climate goals, external factors outside of Sun Life's reasonable control may act as constraints on their achievement, including varying decarbonization efforts across economies, the need for thoughtful climate policies around the world, more and better data, reasonably supported methodologies, technological advancements, the evolution of consumer behaviour, the challenges of balancing interim emissions goals with an orderly and just transition, and other significant considerations such as legal and regulatory obligations. Other factors that may cause actual results and shareholder value to differ materially from those expressed in the forward-looking statements include the impact of the COVID-19 pandemic and related economic conditions on our operations, liquidity, financial conditions or results and the matters set out in 2022 Annual MD&A under the headings D - Profitability - 5 - Income taxes, F - Financial Strength and J - Risk Management and in
Important risk factors that could cause our assumptions and estimates, and expectations and projections to be inaccurate and our actual results or events to differ materially from those expressed in or implied by the forward-looking statements contained in this document, are set out below. The realization of our forward-looking statements, essentially depends on our business performance which, in turn, is subject to many risks. Factors that could cause actual results to differ materially from expectations include, but are not limited to: market risks - related to the performance of equity markets; changes or volatility in interest rates or credit spreads or swap spreads; real estate investments; fluctuations in foreign currency exchange rates; and inflation; insurance risks - related to policyholder behaviour; mortality experience, morbidity experience and longevity; product design and pricing; the impact of higher-than-expected future expenses; and the availability, cost and effectiveness of reinsurance; credit risks - related to issuers of securities held in our investment portfolio, debtors, structured securities, reinsurers, counterparties, other financial institutions and other entities; business and strategic risks - related to global economic and political conditions; the design and implementation of business strategies; changes in distribution channels or Client behaviour including risks relating to market conduct by intermediaries and agents; the impact of competition; the performance of our investments and investment portfolios managed for Clients such as segregated and mutual funds; shifts in investing trends and Client preference towards products that differ from our investment products and strategies; changes in the legal or regulatory environment, including capital requirements and tax laws; the environment, environmental laws and regulations; operational risks - related to breaches or failure of information system security and privacy, including cyber-attacks; our ability to attract and retain employees; legal, regulatory compliance and market conduct, including the impact of regulatory inquiries and investigations; the execution and integration of mergers, acquisitions, strategic investments and divestitures; our information technology infrastructure; a failure of information systems and Internet-enabled technology; dependence on third-party relationships, including outsourcing arrangements; business continuity; model errors; information management; liquidity risks - the possibility that we will not be able to fund all cash outflow commitments as they fall due; and other risks - COVID-19 matters, including its impact on the global economy, and its impact on Sun Life's business, financial condition and or results; risks associated with IFRS 17 Insurance Contracts and IFRS 9 Financial Instruments; our international operations, including our joint ventures; market conditions that affect our capital position or ability to raise capital; downgrades in financial strength or credit ratings; and tax matters, including estimates and judgements used in calculating taxes.
The following risk factors are related to our intention to divest Sun Life
The Company does not undertake any obligation to update or revise its forward-looking statements to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events, except as required by law.
Earnings Conference Call
The Company's Q4'22 financial results will be reviewed at a conference call on
Media Relations Contact:
Director, Corporate Communications
Tel: 226-751-2391
krista.wilson@sunlife.com
Investor Relations Contact:
Vice-President, Head of Investor Relations and Capital Markets
Tel: 416-979-6496
yaniv.bitton@sunlife.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/sun-life-reports-fourth-quarter-and-full-year-2022-results-301742495.html
SOURCE
FAQ
What were Sun Life Financial's Q4 2022 earnings?
How did Sun Life perform in 2022?
What is the stock symbol for Sun Life Financial?
What are the key financial ratios for Sun Life in 2022?